title: [New therapeutics in the suppression of superficial bladder carcinoma].
authors.affiliation: Clinica Urologica Università di Firenze, Divisione di Urologia Ospedale S. Maria Annunziata, Firenze. riccardo.bartoletti@unifi.it
authors.forename: Riccardo
authors.initials: R
authors.lastname: Bartoletti
authors.forename: Tommaso
authors.initials: T
authors.lastname: Cai
authors.forename: Nicola
authors.initials: N
authors.lastname: Mondaini
authors.forename: Umberto
authors.initials: U
authors.lastname: Farina
authors.forename: Franco
authors.initials: F
authors.lastname: Melone
authors.forename: Sandra
authors.initials: S
authors.lastname: Mazzoli
mesh_terms: D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000283:Administration, Intravesical; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001500:BCG Vaccine / Q000627:therapeutic use; D002291:Carcinoma, Papillary / Q000628:therapy*; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives; D015251:Epirubicin / Q000008:administration & dosage; D006801:Humans; D016685:Mitomycin / Q000008:administration & dosage; D016896:Treatment Outcome; D001749:Urinary Bladder Neoplasms / Q000628:therapy*; D000093542:Gemcitabine
chemical_list: D000276:Adjuvants, Immunologic; D001500:BCG Vaccine; D003841:Deoxycytidine; D015251:Epirubicin; D016685:Mitomycin; D000093542:Gemcitabine